journal
https://read.qxmd.com/read/38641553/risk-of-pediatric-bipolar-disorder-after-general-anesthesia-in-infants-and-toddlers-a-propensity-score-matched-population-based-cohort-study
#1
JOURNAL ARTICLE
Mingyang Sun, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang
BACKGROUND AND HYPOTHESIS: The potential role of anesthesia as an independent risk factor for childhood bipolar disorder (BD) remains unclear. To address this, we conducted a population-based cohort study employing propensity score matching to compare BD incidence between pediatric patients undergoing surgery with and without general anesthesia. STUDY DESIGN: Our study included patients aged 0-3 years who received at least 1 episode of general anesthesia and were hospitalized for over 1 day in Taiwan between January 2004 and December 2014...
April 19, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38641344/striatal-response-to-reward-anticipation-as-a-biomarker-for-schizophrenia-and-negative-symptoms-effects-test-retest-reliability-and-stability-across-sites
#2
JOURNAL ARTICLE
Fabien Carruzzo, Mariia Kaliuzhna, Noémie Kuenzi, Tal Geffen, Teresa Katthagen, Florian Schlagenhauf, Stefan Kaiser
BACKGROUND: Ventral striatal hypoactivation during reward anticipation has consistently been observed in patients with schizophrenia. In addition, that hypoactivation has been shown to correlate negatively with negative symptoms, and in particular with apathy. However, little is known about the stability of these results over time and their reliability across different centers. METHODS: In total, 67 patients with schizophrenia (15 females) and 55 healthy controls (13 females) were recruited in 2 centers in Switzerland and Germany...
April 19, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38639321/traumatic-brain-injury-and-risk-of-schizophrenia-and-other-non-mood-psychotic-disorders-findings-from-a-large-inpatient-database-in-the-united-states
#3
JOURNAL ARTICLE
Chintan Trivedi, Preetam Reddy, Abid Rizvi, Karrar Husain, Kimberly Brown, Zeeshan Mansuri, Mahamudun Nabi, Shailesh Jain
BACKGROUND: Traumatic brain injury (TBI) is linked with an increased risk of schizophrenia and other non-mood psychotic disorders (psychotic disorders), but the prevalence and contributing factors of these psychiatric conditions post-TBI remain unclear. This study explores this link to identify key risk factors in TBI patients. METHODS: We used the 2017 National Inpatient Sample dataset. Patients with a history of TBI (n = 26 187) were identified and matched 1:1 by age and gender to controls without TBI (n = 26 187)...
April 18, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38635296/identify-potential-causal-relationships-between-cortical-thickness-mismatch-negativity-neurocognition-and-psychosocial-functioning-in-drug-na%C3%A3-ve-first-episode-psychosis-patients
#4
JOURNAL ARTICLE
Xiaojing Li, Wei Wei, Qiang Wang, Wei Deng, Mingli Li, Xiaohong Ma, Jinkun Zeng, Liansheng Zhao, Wanjun Guo, Mei-Hua Hall, Tao Li
BACKGROUND: Cortical thickness (CT) alterations, mismatch negativity (MMN) reductions, and cognitive deficits are robust findings in first-episode psychosis (FEP). However, most studies focused on medicated patients, leaving gaps in our understanding of the interrelationships between CT, MMN, neurocognition, and psychosocial functioning in unmedicated FEP. This study aimed to employ multiple mediation analysis to investigate potential pathways among these variables in unmedicated drug-naïve FEP...
April 18, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38616054/shared-genetic-determinants-of-schizophrenia-and-autism-spectrum-disorder-implicate-opposite-risk-patterns-a-genome-wide-analysis-of-common-variants
#5
JOURNAL ARTICLE
Yu Chen, Wenqiang Li, Luxian Lv, Weihua Yue
BACKGROUND AND HYPOTHESIS: The synaptic pruning hypothesis posits that schizophrenia (SCZ) and autism spectrum disorder (ASD) may represent opposite ends of neurodevelopmental disorders: individuals with ASD exhibit an overabundance of synapses and connections while SCZ was characterized by excessive pruning of synapses and a reduction. Given the strong genetic predisposition of both disorders, we propose a shared genetic component, with certain loci having differential regulatory impacts...
April 14, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38616053/assessing-trial-by-trial-electrophysiological-and-behavioral-markers-of-attentional-control-and-sensory-precision-in-psychotic-and-mood-disorders
#6
JOURNAL ARTICLE
Megan A Boudewyn, Molly A Erickson, Kurt Winsler, Deanna M Barch, Cameron S Carter, Michael J Frank, James M Gold, Angus W MacDonald, J Daniel Ragland, Steven M Silverstein, Andrew P Yonelinas, Steven J Luck
BACKGROUND AND HYPOTHESIS: The current study investigated the extent to which changes in attentional control contribute to performance on a visual perceptual discrimination task, on a trial-by-trial basis in a transdiagnostic clinical sample. STUDY DESIGN: Participants with schizophrenia (SZ; N = 58), bipolar disorder (N = 42), major depression disorder (N = 51), and psychiatrically healthy controls (N = 92) completed a visual perception task in which stimuli appeared briefly...
April 14, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38613256/long-term-changes-in-personal-recovery-and-quality-of-life-among-patients-with-schizophrenia-spectrum-disorders-and-different-durations-of-illness-a-meta-analysis
#7
JOURNAL ARTICLE
Lars de Winter, Auke Jelsma, Jentien M Vermeulen, Jaap van Weeghel, Ilanit Hasson-Ohayon, Cornelis L Mulder, Nynke Boonstra, Wim Veling, Lieuwe de Haan
BACKGROUND AND HYPOTHESIS: In schizophrenia spectrum disorders (SSD) personal recovery and subjective quality of life (S-QOL) are crucial and show conceptual overlap. There is limited knowledge about how these outcomes change over time. Therefore, we investigated changes in personal recovery or S-QOL for patients with SSD. We specifically focused on the influence of the patients' durations of illness (DOI) on changes in personal recovery and S-QOL. STUDY DESIGN: We included 46 studies investigating longitudinal changes in quantitative assessments of personal recovery or S-QOL for patients with SSD...
April 13, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38581410/adverse-events-reporting-in-digital-interventions-evaluations-for-psychosis-a-systematic-literature-search-and-individual-level-content-analysis-of-adverse-event-reports
#8
JOURNAL ARTICLE
Stephanie Allan, Thomas Ward, Emily Eisner, Imogen H Bell, Matteo Cella, Imran B Chaudhry, John Torous, Tayyeba Kiran, Thomas Kabir, Aansha Priyam, Cara Richardson, Ulrich Reininghaus, Anita Schick, Matthias Schwannauer, Suzy Syrett, Xiaolong Zhang, Sandra Bucci
BACKGROUND: Digital health interventions (DHIs) have significant potential to upscale treatment access to people experiencing psychosis but raise questions around patient safety. Adverse event (AE) monitoring is used to identify, record, and manage safety issues in clinical trials, but little is known about the specific content and context contained within extant AE reports. This study aimed to assess current AE reporting in DHIs. STUDY DESIGN: A systematic literature search was conducted by the iCharts network (representing academic, clinical, and experts by experience) to identify trials of DHIs in psychosis...
April 6, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38581275/glymphatic-system-dysfunction-underlying-schizophrenia-is-associated-with-cognitive-impairment
#9
JOURNAL ARTICLE
Ye Tu, Yan Fang, Guohui Li, Fei Xiong, Feng Gao
BACKGROUND AND HYPOTHESIS: Despite the well-documented structural and functional brain changes in schizophrenia, the potential role of glymphatic dysfunction remains largely unexplored. This study investigates the glymphatic system's function in schizophrenia, utilizing diffusion tensor imaging (DTI) to analyze water diffusion along the perivascular space (ALPS), and examines its correlation with clinical symptoms. STUDY DESIGN: A cohort consisting of 43 people with schizophrenia and 108 healthy controls was examined...
April 6, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38577952/correlation-between-cortical-thickness-abnormalities-of-the-olfactory-sulcus-and-olfactory-identification-disorder-and-persistent-auditory-verbal-hallucinations-in-chinese-patients-with-chronic-schizophrenia
#10
JOURNAL ARTICLE
Honghong Ren, Zongchang Li, Jinguang Li, Jun Zhou, Ying He, Chunwang Li, Qianjin Wang, Xiaogang Chen, Jinsong Tang
BACKGROUND AND HYPOTHESIS: Persistent auditory verbal hallucinations (pAVHs) and olfactory identification impairment are common in schizophrenia (SCZ), but the neuroimaging mechanisms underlying both pAVHs and olfactory identification impairment are unclear. This study aimed to investigate whether pAVHs and olfactory identification impairment in SCZ patients are associated with changes in cortical thickness. STUDY DESIGN: In this study, cortical thickness was investigated in 78 SCZ patients with pAVHs (pAVH group), 58 SCZ patients without AVHs (non-AVH group), and 83 healthy controls (HC group) using 3T magnetic resonance imaging...
April 5, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38577901/distinct-volume-alterations-of-thalamic-nuclei-across-the-schizophrenia-spectrum
#11
JOURNAL ARTICLE
Melissa Thalhammer, Julia Schulz, Felicitas Scheulen, Mohamed El Mehdi Oubaggi, Matthias Kirschner, Stefan Kaiser, André Schmidt, Stefan Borgwardt, Mihai Avram, Felix Brandl, Christian Sorg
BACKGROUND AND HYPOTHESIS: Abnormal thalamic nuclei volumes and their link to cognitive impairments have been observed in schizophrenia. However, whether and how this finding extends to the schizophrenia spectrum is unknown. We hypothesized a distinct pattern of aberrant thalamic nuclei volume across the spectrum and examined its potential associations with cognitive symptoms. STUDY DESIGN: We performed a FreeSurfer-based volumetry of T1-weighted brain MRIs from 137 healthy controls, 66 at-risk mental state (ARMS) subjects, 89 first-episode psychosis (FEP) individuals, and 126 patients with schizophrenia to estimate thalamic nuclei volumes of six nuclei groups (anterior, lateral, ventral, intralaminar, medial, and pulvinar)...
April 5, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38567823/effects-of-benzodiazepine-exposure-on-real-world-clinical-outcomes-in-individuals-at-clinical-high-risk-for-psychosis
#12
JOURNAL ARTICLE
Nicholas R Livingston, Andrea De Micheli, Robert A McCutcheon, Emma Butler, Marwa Hamdan, Anthony A Grace, Philip McGuire, Alice Egerton, Paolo Fusar-Poli, Gemma Modinos
BACKGROUND AND HYPOTHESIS: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences real-world clinical outcomes in individuals at clinical high risk for psychosis (CHR-P) is unknown. STUDY DESIGN: This observational cohort study used electronic health record data from CHR-P individuals to investigate whether BDZ exposure (including hypnotics, eg, zopiclone) reduces the risk of developing psychosis and adverse clinical outcomes...
April 3, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38551332/subgroups-of-clinical-high-risk-for-psychosis-based-on-baseline-antipsychotic-exposure-clinical-and-outcome-comparisons-across-a-2-year-follow-up-period
#13
JOURNAL ARTICLE
Lorenzo Pelizza, Alessandro Di Lisi, Emanuela Leuci, Emanuela Quattrone, Silvia Azzali, Simona Pupo, Giuseppina Paulillo, Pietro Pellegrini, Marco Menchetti
BACKGROUND AND HYPOTHESIS: Antipsychotic (AP) prescription in clinical high risk for psychosis (CHR-P) subjects remains a divisive issue. Although official guidelines currently discourage AP treatment in CHR-P, it is common in clinical practice, especially for psychosis prevention. The aim of this study was to investigate whether baseline AP need (especially in high-dose) indexes a CHR-P subgroup with poorer prognosis and differs from AP-naïve subjects in terms of sociodemographic, clinical, and outcome parameters across a 2-year follow-up...
March 29, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38534050/antipsychotic-use-and-psychiatric-hospitalization-in-first-episode-non-affective-psychosis-and-cannabis-use-disorder-a-swedish-nationwide-cohort-study
#14
JOURNAL ARTICLE
Alexander Denissoff, Heidi Taipale, Jari Tiihonen, Marta Di Forti, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Antti Mustonen, Solja Niemelä
BACKGROUND AND HYPOTHESIS: There is a paucity of research on treatment outcomes of patients with psychosis and cannabis use disorder (CUD). We aimed to compare the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis (FEP) and co-occurring CUD. STUDY DESIGN: We utilized a nationwide Swedish cohort of patients with longitudinal register data from the year 2006 to 2021. Participants were patients with FEP and co-occurring CUD (n = 1820, 84...
March 26, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38525604/early-intervention-in-psychosis-and-management-of-first-episode-psychosis-in-low-and-lower-middle-income-countries-a-systematic-review
#15
JOURNAL ARTICLE
Saeed Farooq, Nishani Fonseka, Malik Wajid Ali, Abbie Milner, Shumaila Hamid, Saima Sheikh, Muhammad Firaz Khan, Mian Mukhtar-Ul-Haq Azeemi, Gayan Ariyadasa, Abdul Jalil Khan, Muhammad Ayub
BACKGROUND AND HYPOTHESIS: People with first-episode psychosis (FEP) in low- and lower-middle-income countries (LMIC) experience delays in receiving treatment, resulting in poorer outcomes and higher mortality. There is robust evidence for effective and cost-effective early intervention in psychosis (EIP) services for FEP, but the evidence for EIP in LMIC has not been reviewed. We aim to review the evidence on early intervention for the management of FEP in LMIC. STUDY DESIGN: We searched 4 electronic databases (Medline, Embase, PsycINFO, and CINAHL) to identify studies describing EIP services and interventions to treat FEP in LMIC published from 1980 onward...
March 25, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38525594/adolescent-stress-induced-ventral-hippocampus-redox-dysregulation-underlies-behavioral-deficits-and-excitatory-inhibitory-imbalance-related-to-schizophrenia
#16
JOURNAL ARTICLE
Thamyris Santos-Silva, Caio Fábio Baeta Lopes, Doğukan Hazar Ülgen, Danielle A Guimarães, Francisco S Guimarães, Luciane Carla Alberici, Carmen Sandi, Felipe V Gomes
BACKGROUND AND HYPOTHESIS: Redox dysregulation has been proposed as a convergent point of childhood trauma and the emergence of psychiatric disorders, such as schizophrenia (SCZ). A critical region particularly vulnerable to environmental insults during adolescence is the ventral hippocampus (vHip). However, the impact of severe stress on vHip redox states and their functional consequences, including behavioral and electrophysiological changes related to SCZ, are not entirely understood...
March 25, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38525590/service-user-representation-in-qualitative-research-on-cognitive-health-and-related-interventions-for-psychosis-a-scoping-review
#17
JOURNAL ARTICLE
Lauren Gonzales, Nev Jones
BACKGROUND AND HYPOTHESIS: Cognitive health in schizophrenia spectrum psychosis has received substantial empirical attention in recent decades, coinciding with the development and implementation of interventions including cognitive remediation. Subjective experience in psychosis, including qualitative explorations of service user perspectives, has also proliferated; however, there is no available synthesis of service user representation in the psychosis cognitive health literature. This scoping review investigated prevalence and characteristics of qualitative research reporting service user perspectives across the extant research on cognitive health and related interventions in psychosis...
March 25, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38522431/intensive-longitudinal-social-sensing-in-patients-with-psychosis-spectrum-disorders-an-exploratory-pilot-study
#18
JOURNAL ARTICLE
Moritz von Heyden, Paul Grube, Markus Sack, Johannes Wiesner, Oliver Frank, Kathrin Becker, Stefan Heintz, Iris Reinhard, Sarah Hohmann, Dusan Hirjak, Andreas Meyer-Lindenberg, Urs Braun
BACKGROUND: Psychosis spectrum disorders are characterized by significant alterations in social functioning, which is a major factor for patient recovery. Despite its importance, objectively quantifying the complex day-to-day social behavior in real-life settings has rarely been attempted. Here, we conducted a pilot study with wearable sensors that passively and continuously register interactions with other participants. We hypothesized that the amount and pattern of social interaction was associated with the severity of psychotic symptoms...
March 24, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38517180/implementation-of-cognitive-health-services-in-large-systems-of-care-highlights-from-coordinated-specialty-care-for-first-episode-psychosis
#19
JOURNAL ARTICLE
Alice M Saperstein, Iruma Bello, Ilana Nossel, Lisa B Dixon, Alice Medalia
BACKGROUND AND HYPOTHESIS: With increasing recognition of the importance of cognitive health for recovery in people with psychosis, questions arise as to how to implement cognitive health services in large systems of care. This paper describes the implementation of cognitive health services in OnTrackNY (OTNY), a network of clinics delivering a Coordinated Specialty Care treatment model for early psychosis, with the goal of documenting the processes, challenges, and useful adaptations...
March 22, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38502910/successful-clozapine-rechallenge-after-clozapine-induced-severe-anemia-a-case-report
#20
JOURNAL ARTICLE
Felipe Mendonça Rocha Barros, Arthur Cardoso Tolentino, Lais Soares Ker Marques, Leandro Xavier de Camargo Schlittler, Karina Diniz Oliveira, Paulo Dalgalarrondo, Lucas Luchesi Barnes, Amilton Dos Santos Junior, Claudio Eduardo Muller Banzato
INTRODUCTION: Clozapine, a second-generation antipsychotic (SGA), is considered the gold standard medication to treat patients with treatment-resistant schizophrenia (TRS). Despite its efficacy, clozapine is associated with adverse effects, notably neutropenia and agranulocytosis. Other hematological adverse effects are less common. Severe anemia is a rare adverse effect seldom reported in the literature and is typically associated with pure red cell aplasia (PRCA). Nevertheless, the benefits of clozapine in managing TRS make rechallenge a reasonable option...
March 19, 2024: Schizophrenia Bulletin
journal
journal
22417
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.